Explore the Potential with AI-Driven Innovation
The specialised, focused library is developed on demand with the most recent virtual screening and parameter assessment technology, guided by the Receptor.AI drug discovery platform. This approach exceeds the capabilities of traditional methods and offers compounds with higher activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes in-depth molecular simulations of both the catalytic and allosteric binding pockets, with ensemble virtual screening focusing on their conformational flexibility. For modulators, the process includes considering the structural shifts due to reaction intermediates to boost activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
Q7Z4H3
UPID:
HDDC2_HUMAN
Alternative names:
HD domain-containing protein 2; Hepatitis C virus NS5A-transactivated protein 2
Alternative UPACC:
Q7Z4H3; Q5TDQ4; Q6NZ49; Q9BTT2; Q9BV31; Q9Y3D1
Background:
5'-deoxynucleotidase HDDC2, also known as HD domain-containing protein 2 and Hepatitis C virus NS5A-transactivated protein 2, plays a crucial role in cellular metabolism by catalyzing the dephosphorylation of nucleoside 5'-monophosphates. This enzymatic activity is essential for the regulation of nucleotide pools within the cell, ensuring the proper balance for DNA replication and repair processes.
Therapeutic significance:
Understanding the role of 5'-deoxynucleotidase HDDC2 could open doors to potential therapeutic strategies. Its pivotal function in nucleotide metabolism positions it as a key target for interventions in diseases where DNA replication and repair mechanisms are compromised.